Entest Biomedical's market value is the price at which a share of Entest Biomedical trades on a public exchange. It measures the collective expectations of Entest Biomedical investors about its performance. Entest Biomedical is trading at 2.0E-4 as of the 26th of December 2025. This is a No Change since the beginning of the trading day. The stock's open price was 2.0E-4. With this module, you can estimate the performance of a buy and hold strategy of Entest Biomedical and determine expected loss or profit from investing in Entest Biomedical over a given investment horizon. Check out Entest Biomedical Correlation, Entest Biomedical Volatility and Entest Biomedical Alpha and Beta module to complement your research on Entest Biomedical.
Please note, there is a significant difference between Entest Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Entest Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Entest Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Entest Biomedical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Entest Biomedical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Entest Biomedical.
0.00
11/26/2025
No Change 0.00
0.0
In 31 days
12/26/2025
0.00
If you would invest 0.00 in Entest Biomedical on November 26, 2025 and sell it all today you would earn a total of 0.00 from holding Entest Biomedical or generate 0.0% return on investment in Entest Biomedical over 30 days. Entest Biomedical is related to or competes with China Senior. It intends to seek business opportunities to review and analyze for purposes of effecting a merger, acquisition, or othe... More
Entest Biomedical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Entest Biomedical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Entest Biomedical upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Entest Biomedical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Entest Biomedical's standard deviation. In reality, there are many statistical measures that can use Entest Biomedical historical prices to predict the future Entest Biomedical's volatility.
Entest Biomedical is out of control given 3 months investment horizon. Entest Biomedical secures Sharpe Ratio (or Efficiency) of 0.11, which denotes the company had a 0.11 % return per unit of risk over the last 3 months. We were able to interpolate sixteen different technical indicators, which can help you to evaluate if expected returns of 14.22% are justified by taking the suggested risk. Use Entest Biomedical Standard Deviation of 234.8, variance of 55131.46, and Mean Deviation of 56.79 to evaluate company specific risk that cannot be diversified away. Entest Biomedical holds a performance score of 8 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 18.73, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Entest Biomedical will likely underperform. Use Entest Biomedical treynor ratio and day median price , to analyze future returns on Entest Biomedical.
Auto-correlation
0.00
No correlation between past and present
Entest Biomedical has no correlation between past and present. Overlapping area represents the amount of predictability between Entest Biomedical time series from 26th of November 2025 to 11th of December 2025 and 11th of December 2025 to 26th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Entest Biomedical price movement. The serial correlation of 0.0 indicates that just 0.0% of current Entest Biomedical price fluctuation can be explain by its past prices.
Correlation Coefficient
0.0
Spearman Rank Test
1.0
Residual Average
0.0
Price Variance
0.0
Entest Biomedical lagged returns against current returns
Autocorrelation, which is Entest Biomedical pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Entest Biomedical's pink sheet expected returns. We can calculate the autocorrelation of Entest Biomedical returns to help us make a trade decision. For example, suppose you find that Entest Biomedical has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
Entest Biomedical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Entest Biomedical pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Entest Biomedical pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Entest Biomedical pink sheet over time.
Current vs Lagged Prices
Timeline
Entest Biomedical Lagged Returns
When evaluating Entest Biomedical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Entest Biomedical pink sheet have on its future price. Entest Biomedical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Entest Biomedical autocorrelation shows the relationship between Entest Biomedical pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Entest Biomedical.
Other Information on Investing in Entest Pink Sheet
Entest Biomedical financial ratios help investors to determine whether Entest Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Entest with respect to the benefits of owning Entest Biomedical security.